42
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Highly Functional Synthetic Phage Display Library Containing over 40 Billion Human Antibody Clones

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Several synthetic antibody phage display libraries have been created and used for the isolation of human monoclonal antibodies. The performance of antibody libraries, which is usually measured in terms of their ability to yield high-affinity binding specificities against target proteins of interest, depends both on technical aspects (such as library size and quality of cloning) and on design features (which influence the percentage of functional clones in the library and their ability to be used for practical applications). Here, we describe the design, construction and characterization of a combinatorial phage display library, comprising over 40 billion human antibody clones in single-chain fragment variable (scFv) format. The library was designed with the aim to obtain highly stable antibody clones, which can be affinity-purified on protein A supports, even when used in scFv format. The library was found to be highly functional, as >90% of randomly selected clones expressed the corresponding antibody. When selected against more than 15 antigens from various sources, the library always yielded specific and potent binders, at a higher frequency compared to previous antibody libraries. To demonstrate library performance in practical biomedical research projects, we isolated the human antibody G5, which reacts both against human and murine forms of the alternatively spliced BCD segment of tenascin-C, an extracellular matrix component frequently over-expressed in cancer and in chronic inflammation. The new library represents a useful source of binding specificities, both for academic research and for the development of antibody-based therapeutics.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

          G. Smith (1985)
          Foreign DNA fragments can be inserted into filamentous phage gene III to create a fusion protein with the foreign sequence in the middle. The fusion protein is incorporated into the virion, which retains infectivity and displays the foreign amino acids in immunologically accessible form. These "fusion phage" can be enriched more than 1000-fold over ordinary phage by affinity for antibody directed against the foreign sequence. Fusion phage may provide a simple way of cloning a gene when an antibody against the product of that gene is available.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

            A biosynthetic antibody binding site, which incorporated the variable domains of anti-digoxin monoclonal antibody 26-10 in a single polypeptide chain (Mr = 26,354), was produced in Escherichia coli by protein engineering. This variable region fragment (Fv) analogue comprised the 26-10 heavy- and light-chain variable regions (VH and VL) connected by a 15-amino acid linker to form a single-chain Fv (sFv). The sFv was designed as a prolyl-VH-(linker)-VL sequence of 248 amino acids. A 744-base-pair DNA sequence corresponding to this sFv protein was derived by using an E. coli codon preference, and the sFv gene was assembled starting from synthetic oligonucleotides. The sFv polypeptide was expressed as a fusion protein in E. coli, using a leader derived from the trp LE sequence. The sFv protein was obtained by acid cleavage of the unique Asp-Pro peptide bond engineered at the junction of leader and sFv in the fusion protein [(leader)-Asp-Pro-VH-(linker)-VL]. After isolation and renaturation, folded sFv displayed specificity for digoxin and related cardiac glycosides similar to that of natural 26-10 Fab fragments. Binding between affinity-purified sFv and digoxin exhibited an association constant [Ka = (3.2 +/- 0.9) x 10(7) M-1] that was about a factor of 6 smaller than that found for 26-10 Fab fragments [Ka = (1.9 +/- 0.2) x 10(8) M-1] under the same buffer conditions, consisting of 0.01 M sodium acetate, pH 5.5/0.25 M urea.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Standard conformations for the canonical structures of immunoglobulins.

              A comparative analysis of the main-chain conformation of the L1, L2, L3, H1 and H2 hypervariable regions in 17 immunoglobulin structures that have been accurately determined at high resolution is described. This involves 79 hypervariable regions in all. We also analysed a part of the H3 region in 12 of the 15 VH domains considered here. On the basis of the residues at key sites the 79 hypervariable regions can be assigned to one of 18 different canonical structures. We show that 71 of these hypervariable regions have a conformation that is very close to what can be defined as a "standard" conformation of each canonical structure. These standard conformations are described in detail. The other eight hypervariable regions have small deviations from the standard conformations that, in six cases, involve only the rotation of a single peptide group. Most H3 hypervariable regions have the same conformation in the part that is close to the framework and the details of this conformation are also described here. Copyright 1997 Academic Press Limited
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2014
                20 June 2014
                : 9
                : 6
                : e100000
                Affiliations
                [1 ]Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, Zürich, Switzerland
                [2 ]Philochem AG, Otelfingen, Switzerland
                Imperial College London, United Kingdom
                Author notes

                Competing Interests: We have read the journal’s policy and have the following conflicts. Dario Neri is a cofounder and shareholder of Philochem AG. Some authors were (MW, EB, AP, AV, TH) or are (MM, LG, SW) employed by Philochem AG, the company which owns the PHILODiamond Library. The conflicts of interest do not alter our adherence to PLOS ONE policies on sharing data and materials. The full information about the library construction (including sequences and oligos) is available in the paper.

                Conceived and designed the experiments: MW AV SW DN. Performed the experiments: MW EB AP MM LG TH. Analyzed the data: MW EB AP AV MM LG SW DN. Contributed reagents/materials/analysis tools: MW EB AP AV MM LG SW TH DN. Wrote the paper: MW DN.

                Article
                PONE-D-14-10166
                10.1371/journal.pone.0100000
                4065035
                24950200
                4ffb42d5-6be4-4fbe-91d6-455d5a5d2224
                Copyright @ 2014

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 5 March 2014
                : 20 May 2014
                Page count
                Pages: 9
                Funding
                ETH Zurich, KTI, Philochem AG. The funder provided support in the form of salaries for authors (MW, EB, AP, AV, TH, MM, LG, SW, DN), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.
                Categories
                Research Article
                Biology and Life Sciences
                Biotechnology
                Bioengineering
                Synthetic Bioengineering
                Macromolecular Engineering
                Protein Engineering
                Antibody Engineering
                Molecular Biology
                Molecular Biology Techniques
                Cloning
                Antibody Cloning
                Molecular Biology Assays and Analysis Techniques
                Molecular Biology Display Techniques
                Phage Display
                Medicine and Health Sciences
                Oncology
                Basic Cancer Research
                Cancer Drug Discovery
                Pharmacology
                Drug Research and Development
                Drug Discovery
                Custom metadata
                The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.

                Uncategorized
                Uncategorized

                Comments

                Comment on this article